Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FS6SK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,549
Award facts
- Contract value 100% obligated
- $50,548.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $50,548.80 to AmerisourceBergen Drug Corp for HEPLISAV-B 20 MCG/0.5 ML syringes on September 26, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. HEPLISAV-B is a recombinant hepatitis B vaccine indicated for prevention of hepatitis B infection. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and running through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, specialty medications, and medical devices across multiple therapeutic domains. The contract supports critical healthcare operations for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FS6SK?
SPE2DB25FS6SK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FS6SK worth?
The government has obligated $50,549 on SPE2DB25FS6SK.
Is contract SPE2DB25FS6SK an order under another contract?
Yes. SPE2DB25FS6SK is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS6SK competed?
The extent of competition for SPE2DB25FS6SK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award